Following TfR-BiTE-mediated tumor lysis, both CD8 and CD4 T-cell subsets maintained an activated phenotype as shown by expression of the early activation marker CD69 and cytotoxic granule granzyme B (GrB). The gene discussed is CD8A; the disease is neoplasm.